These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2106591)

  • 1. Update on chronic granulomatous diseases of childhood. Immunotherapy and potential for gene therapy.
    Gallin JI; Malech HL
    JAMA; 1990 Mar; 263(11):1533-7. PubMed ID: 2106591
    [No Abstract]   [Full Text] [Related]  

  • 2. The NADPH oxidase and chronic granulomatous disease.
    Segal AW
    Mol Med Today; 1996 Mar; 2(3):129-35. PubMed ID: 8796870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood.
    Gallin JI; Leto TL; Rotrosen D; Kwong CH; Malech HL
    Curr Opin Immunol; 1992 Feb; 4(1):53-6. PubMed ID: 1317712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood.
    Gallin JI
    Int J Tissue React; 1993; 15(3):99-103. PubMed ID: 8188451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The respiratory burst oxidase.
    Babior BM
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):201-12. PubMed ID: 2839456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of chronic granulomatous disease.
    Orkin SH
    Annu Rev Immunol; 1989; 7():277-307. PubMed ID: 2523713
    [No Abstract]   [Full Text] [Related]  

  • 7. Is the IFN-gamma-induced enhancement of superoxide production in CGD-phagocytes caused by increased expression of the p47-phox cytosolic protein.
    Jendrossek V; Damm U; Liese J; Belohradsky BH; Gahr M
    Immunodeficiency; 1993; 4(1-4):187-90. PubMed ID: 8167697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.
    Bemiller LS; Roberts DH; Starko KM; Curnutte JT
    Blood Cells Mol Dis; 1995; 21(3):239-47. PubMed ID: 8673477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the NADPH-oxidase: membrane components.
    Segal AW
    Immunodeficiency; 1993; 4(1-4):167-79. PubMed ID: 8167695
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.
    Newburger PE; Ezekowitz RA
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):267-76. PubMed ID: 2839459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A variant of chronic granulomatous disease: deficient oxidative metabolism due to a low-affinity NADPH oxidase.
    Lew PD; Southwick FS; Stossel TP; Whitin JC; Simons E; Cohen HJ
    N Engl J Med; 1981 Nov; 305(22):1329-33. PubMed ID: 6270561
    [No Abstract]   [Full Text] [Related]  

  • 12. Topics in chronic granulomatous disease.
    Umeki S
    Pediatrics; 1991 Jul; 88(1):183-5. PubMed ID: 2057262
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic granulomatous disease.
    Dinauer MC; Orkin SH
    Annu Rev Med; 1992; 43():117-24. PubMed ID: 1316094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome b-245 and its involvement in the molecular pathology of chronic granulomatous disease.
    Segal AW
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):213-23. PubMed ID: 3292507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and current management of chronic granulomatous disease.
    Forrest CB; Forehand JR; Axtell RA; Roberts RL; Johnston RB
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):253-66. PubMed ID: 2839458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic granulomatous disease.
    Babior BM; Woodman RC
    Semin Hematol; 1990 Jul; 27(3):247-59. PubMed ID: 2197728
    [No Abstract]   [Full Text] [Related]  

  • 17. [Activation mechanism of neutrophil NADPH oxidase complex--molecular pathology of chronic granulomatous disease].
    Umeki S
    Tanpakushitsu Kakusan Koso; 1994 Nov; 39(14):2284-96. PubMed ID: 7809374
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic granulomatous disease: an update and a paradigm for the use of interferon-gamma as adjunct immunotherapy in infectious diseases.
    Ezekowitz RA
    Curr Top Microbiol Immunol; 1992; 181():283-92. PubMed ID: 1424784
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular basis of chronic granulomatous disease.
    Smith RM; Curnutte JT
    Blood; 1991 Feb; 77(4):673-86. PubMed ID: 1993212
    [No Abstract]   [Full Text] [Related]  

  • 20. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.
    Leusen JH; de Boer M; Bolscher BG; Hilarius PM; Weening RS; Ochs HD; Roos D; Verhoeven AJ
    J Clin Invest; 1994 May; 93(5):2120-6. PubMed ID: 8182143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.